Drug distributors and Teva reach settlement in Ohio opioid litigation: WSJ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Ohio Opioid Deal Worth About $250M from AmerisourceBergen (ABC), Teva (TEVA), McKesson (MCK) and Cardinal Health (CAH) - Bloomberg
October 21, 2019 8:26 AM EDTOhio Opioid Deal Worth About $250M from AmerisourceBergen (NYSE: ABC), Teva (NYSE: TEVA), McKesson (NYSE: MCK) and Cardinal Health (NYSE: CAH) - Bloomberg
